Literature DB >> 19663546

The role of T helper cell differentiation in promoting nerve allograft survival with costimulation blockade.

Wilson Z Ray1, Rahul Kasukurthi, Esther M Papp, Amy M Moore, Andrew Yee, Daniel A Hunter, Nancy L Solowski, Thalachallour Mohanakumar, Susan E Mackinnon, Thomas H Tung.   

Abstract

OBJECT: Peripheral nerve allografts provide a temporary scaffold for host nerve regeneration and allow for the repair of significant segmental nerve injuries. Despite this potential, nerve allograft transplantation requires temporary systemic immunosuppression. Characterization of the immunological mechanisms involved in the induction of immune hyporesponsiveness to prevent nerve allograft rejection will help provide a basis for optimizing immunomodulation regimens or manipulating donor nerve allografts to minimize or eliminate the need for global immunosuppression.
METHODS: The authors used C57Bl/6 mice and STAT4 and STAT6 gene BALB/c knockout mice. A nonvascularized nerve allograft was used to reconstruct a 1-cm sciatic nerve gap in the murine model. A triple costimulatory blockade of the CD40, CD28/B7, and inducible costimulatory (ICOS) pathways was used. Quantitative assessment was performed at 3 weeks with nerve histomorphometry, walking track analysis, and the enzyme-linked immunospot assay.
RESULTS: The STAT6 -/- mice received 3 doses of costimulation-blocking antibodies and had axonal regeneration equivalent to nerve isografts, while treated STAT4 -/- mice demonstrated moderate axonal regeneration but inferior to the T helper cell Type 2-deficient animals. Enzyme-linked immunospot assay analysis demonstrated a minimal immune response in both STAT4 -/- and STAT6 -/- mice treated with a costimulatory blockade.
CONCLUSIONS: The authors' findings suggest that Type 1 T helper cells may play a more significant role in costimulatory blockade-induced immune hyporesponsiveness in the nerve allograft model, and that Type 2 T helper differentation may represent a potential target for directed immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19663546      PMCID: PMC2956431          DOI: 10.3171/2009.7.JNS09187

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  65 in total

1.  B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.

Authors:  D A Mandelbrot; M A Oosterwegel; K Shimizu; A Yamada; G J Freeman; R N Mitchell; M H Sayegh; A H Sharpe
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection.

Authors:  Cécile Guillot; Carole Guillonneau; Patrick Mathieu; Christian A Gerdes; Séverine Ménoret; Cécile Braudeau; Laurent Tesson; Karine Renaudin; Maria G Castro; Pedro R Löwenstein; Ignacio Anegon
Journal:  J Immunol       Date:  2002-02-15       Impact factor: 5.422

3.  Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection.

Authors:  E Ozkaynak; W Gao; N Shemmeri; C Wang; J C Gutierrez-Ramos; J Amaral; S Qin; J B Rottman; A J Coyle; W W Hancock
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

4.  ICOS co-stimulatory receptor is essential for T-cell activation and function.

Authors:  C Dong; A E Juedes; U A Temann; S Shresta; J P Allison; N H Ruddle; R A Flavell
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

5.  Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.

Authors:  Andre van van Maurik; Manuela Herber; Kathryn J Wood; Nick D Jones
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

6.  CD28-independent costimulation of T cells in alloimmune responses.

Authors:  A Yamada; K Kishimoto; V M Dong; M Sho; A D Salama; N G Anosova; G Benichou; D A Mandelbrot; A H Sharpe; L A Turka; H Auchincloss; M H Sayegh
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

7.  Axonal regeneration after cold preservation of nerve allografts and immunosuppression with tacrolimus in mice.

Authors:  Aaron G Grand; Terence M Myckatyn; Susan E Mackinnon; Daniel A Hunter
Journal:  J Neurosurg       Date:  2002-05       Impact factor: 5.115

8.  Resistance to metastatic disease in STAT6-deficient mice requires hemopoietic and nonhemopoietic cells and is IFN-gamma dependent.

Authors:  Suzanne Ostrand-Rosenberg; Virginia K Clements; Masaki Terabe; Jong Myun Park; Jay A Berzofsky; Samudra K Dissanayake
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

9.  Functional recovery and histomorphometric assessment following tibial nerve injury in the mouse.

Authors:  Laura T George; Terence M Myckatyn; John N Jensen; Daniel A Hunter; Susan E Mackinnon
Journal:  J Reconstr Microsurg       Date:  2003-01       Impact factor: 2.873

Review 10.  T-cell regulation by CD28 and CTLA-4.

Authors:  M L Alegre; K A Frauwirth; C B Thompson
Journal:  Nat Rev Immunol       Date:  2001-12       Impact factor: 53.106

View more
  3 in total

1.  Dynamic quantification of host Schwann cell migration into peripheral nerve allografts.

Authors:  Elizabeth L Whitlock; Terence M Myckatyn; Alice Y Tong; Andrew Yee; Ying Yan; Christina K Magill; Philip J Johnson; Susan E Mackinnon
Journal:  Exp Neurol       Date:  2010-07-12       Impact factor: 5.330

2.  Costimulation blockade inhibits the indirect pathway of allorecognition in nerve allograft rejection.

Authors:  Wilson Z Ray; Rahul Kasukurthi; Santosh S Kale; Katherine B Santosa; Daniel A Hunter; Philip Johnson; Ying Yan; Thalachallour Mohanakumar; Susan E Mackinnon; Thomas H Tung
Journal:  Muscle Nerve       Date:  2011-01       Impact factor: 3.217

3.  Limited regeneration in long acellular nerve allografts is associated with increased Schwann cell senescence.

Authors:  Maryam Saheb-Al-Zamani; Ying Yan; Scott J Farber; Daniel A Hunter; Piyaraj Newton; Matthew D Wood; Sheila A Stewart; Philip J Johnson; Susan E Mackinnon
Journal:  Exp Neurol       Date:  2013-05-03       Impact factor: 5.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.